Pharmaceutical Industry

Hokochemie GmbH 

Weggis · Since 1994

Hokochemie is a manufacturer of generics, particularly in the field of Life Sciences. The company's core activities include the development and production of products for public health, animal health, and human health. The company offers a wide range of products, including specific solutions such as Hokoex Fly Control, an insecticide for controlling flies.

Holistic Health Swiss AG 

Zug · Since 2023

The core activity of Holistic Health Swiss AG is the development, manufacture and marketing of natural dietary supplements and health products, in particular plant-based formulations aimed at supporting the immune system, energy and holistic health.

Horus Pharma Suisse SA 

Nyon · Since 2021

The core activity of Horus Pharma is the development, manufacture and marketing of pharmaceuticals, medical devices and dietary supplements, particularly in the fields of ophthalmology, dermatology and surgery. The company focuses on creating therapeutic solutions and accompanying services for doctors and patients, with an emphasis on innovation, ethics and patient benefit.

HRA-Pharma Switzerland Sàrl 

Nyon · Since 2009

Humabs BioMed SA 

Bellinzona · Since 2011

The core activity of Humabs BioMed SA is the discovery and development of anti-infective immunotherapies for the treatment of viral and bacterial diseases, including those caused by Zika, Ebola, Rabies, Dengue and other Flaviviruses. The company focuses on the development of therapeutics up to clinical proof of concept and has a broad pipeline of development candidates.

Hylamed Surgical AG 

Egg B. Zürich · Since 2006

IBSA Institut Biochimique SA 

Pazzallo · Since 1945

IBSA Institut Biochimique SA is a multinational pharmaceutical company that develops, manufactures and commercializes medicinal products. Its portfolio covers therapeutic areas including reproductive medicine, endocrinology, pain and inflammation, osteo‑articular conditions, aesthetic medicine, dermatology, uro‑gynecology, cardiometabolic and respiratory diseases and consumer health, and includes hyaluronic acid–based products as well as pharmaceutical formulations and delivery systems.

ICON Clinical Research (Switzerland) GmbH 

Basel · Since 1998

The company ICON is a service provider to the pharmaceutical industry, focusing on clinical research, medical communication, and market access. The core activities include: * Clinical Research: Conducting clinical trials, including decentralized clinical trials, early-phase studies, and bioanalysis * Medical Communication: Creating medical content, such as publications, presentations, and marketing materials * Market Access: Supporting pharmaceutical companies in launching medicines, including health economics, outcomes research, and market research * Laboratory Services: Bioanalysis, biomarker development and analysis, as well as other laboratory services * Consulting: Strategic consulting for pharmaceutical companies in the areas of clinical research, market access, and medical communication The company also offers specialized services such as risk management, safety reporting, and regulatory affairs.

iGreen Swiss SA 

Henniez · Since 2017

The core activity of iGreen Swiss S.A. is the development, production and distribution of medical cannabis and its derived products, in particular Tetrahydrocannabinol (THC) and Cannabidiol (CBD), for therapeutic purposes. The company is active in all phases of the value chain, from research and development to the manufacture and marketing of medical cannabis and its derived products.

IMCD Switzerland AG 

Zurich · Since 1957

IMCD is a distributor and service provider for the chemical and pharmaceutical industries. The company's core activity is to create value for its business partners by offering a wide range of services, including distribution, marketing, technical support, and formulation. IMCD supports its customers in achieving their sustainability goals and provides consulting and technical support in implementing new solutions. The company has a global network and supports its customers across various industries.

Immunocore GmbH 

Rotkreuz · Since 2022

Immunocore GmbH is a commercial-stage biotechnology company that develops and commercializes T cell receptor (TCR)-based immunotherapies. Using its proprietary ImmTAX platform, the company develops bispecific TCR therapies for oncology, infectious diseases and autoimmune conditions and maintains a pipeline of clinical and preclinical programs, including the approved therapy KIMMTRAK (tebentafusp) for certain uveal melanoma patients.

Immunovant Sciences GmbH 

Basel · Since 2018

Immunovant Sciences GmbH is a clinical-stage immunology company developing anti‑FcRn therapies, including IMVT‑1402 and batoclimab, to reduce pathogenic IgG autoantibodies in autoimmune diseases. The product candidates are described as fully human monoclonal antibodies intended for subcutaneous administration with dosing that may be tailored to disease stage and severity.

InCephalo AG 

Allschwil · Since 2021

The core activity of InCephalo Therapeutics is the development and research of local therapies for neurological diseases, particularly brain cancer. The company focuses on the development of biological drugs specifically designed for local application in the central nervous system (CNS) to minimize side effects and maximize efficacy. The proprietary Compartment Lock technology (C-Lock) enables the local retention of biological drugs in the CNS, prolonging their effect while minimizing systemic exposure.

Inceptua Swiss SA 

Bioggio · Since 2024

Inceptua Swiss SA is a pharmaceutical services company providing clinical trial supply and early-access programmes. Its services include supply of medicines and ancillaries, packaging and labelling, storage and distribution, and the distribution of licensed and unlicensed medicines.

Inceptua SA, Luxembourg, Succursale di Bioggio 

Bioggio · Since 1997

Inceptua SA, Luxembourg, Succursale di Bioggio is part of the Inceptua Group and provides pharmaceutical services. Its activities include clinical trial supply (medicines and ancillaries), packaging and labelling, storage and distribution, and the design and implementation of early‑access and unlicensed medicines programmes.

Indivior Schweiz AG 

Baar · Since 2015

Indivior Schweiz AG is a specialty pharmaceutical company focused on evidence-based treatment and advancing understanding of opioid use disorder (OUD). It develops and provides therapies, including buprenorphine-based treatments, and conducts research to support long-term recovery.

INFLAMALPS SA 

Monthey · Since 2012

The core activity of Inflamalps SA is the development of biopharmaceutical products, particularly the discovery and development of anti-inflammatory and anti-microbial molecules for the treatment of diseases, such as dry eye in ophthalmology.

InkVivo Technologies SA 

Lugano · Since 2023

The core activity of InkVivo Technologies AG is the development and manufacture of innovative drug and nutritional supplement release systems, which are produced using additive manufacturing (3D printing) and a scalable platform technology. These systems enable targeted, local and prolonged release of active ingredients, nutritional supplements and cells. The company focuses on revolutionizing drug delivery and release in the body.

InnoMedica Schweiz AG 

Bern · Since 1988

The core activity of InnoMedica is the development and production of nanotransport systems for the pharmaceutical industry, particularly for oncology, neurology and immunology. The company focuses on researching and developing nanocarriers that can release active ingredients in a targeted manner in the body, aiming to achieve improved efficacy with reduced side effects. Production takes place in its own GMP-certified nanofactory, which covers the entire value chain from raw material production to final product manufacturing.

INOFEA AG 

Muttenz · Since 2014

The core activity of INOFEA AG is the development of enzyme-based solutions for the optimized synthesis of high-quality compounds in production processes.